• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP SYPHILIS (SYPH); SYPHILIS ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP SYPHILIS (SYPH); SYPHILIS ASSAY Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/19/2017
Event Type  malfunction  
Manufacturer Narrative
The cause for the discordant (b)(6) results is unknown.The patient sample is not available for additional testing at the manufacturer's site due to (b)(6) customs regulations.Siemens healthcare diagnostics is investigating.The ifu states in the interpretation of results section: "results should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." the ifu states in the limitations section: "a nonreactive test result does not exclude the possibility of exposure to or infection with syphilis.T.Pallidum antibodies may be undetectable in some stages of the infection and in some clinical conditions.Assay performance characteristics have not been established when the advia centaur syph assay is used in conjunction with other manufacturers' assays for specific syphilis serological markers.".
 
Event Description
A (b)(6) advia centaur xp (b)(6) result was obtained for a patient sample.The patient sample was tested on three alternate methods and the results were reactive.A previous sample from the same patients was tested in (b)(6) 2016.The results were (b)(6) on the advia centaur xp (b)(6) assay and (b)(6) on the three alternate methods.The patient was considered (b)(6) for (b)(6) testing.The patient sample was tested at another laboratory on the advia centaur xp (b)(6) assay and the results were (b)(6).Patient treatment was not altered or prescribed.There was no report of adverse health consequences due to the discordant advia centaur xp (b)(6) results.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2017-00118 on july 31, 2017.07/31/2017 additional information: the customer was not able to send the sample for additional testing due to argentinian customs regulations.Therefore, siemens is unable to determine the cause of the discordant result.The patient has a history of negative results with the advia centaur xp syphilis assay.Based on the information provided from the customer, siemens is unable to rule out a sample specific issue as the cause for the false negative result.The cause for the discordant syphilis (syph) results is unknown.The instrument is performing within specifications.No further evaluation of the device is required.The ifu states in the limitations section: a nonreactive test result does not exclude the possibility of exposure to or infection with syphilis.T.Pallidum antibodies may be undetectable in some stages of the infection and in some clinical conditions.The ifu states in the summary and explanation section: "nontreponemal tests have poor sensitivity and specificity, and recombinant antigen-based treponemal tests have higher sensitivity and specificity than native antigen-based treponemal tests." the ifu states in the interpretation of results section: "results should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP SYPHILIS (SYPH)
Type of Device
SYPHILIS ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
e. walpole MA 02032
Manufacturer Contact
eiman sulieman
333 coney street
e. walpole, MA 02032
5086604603
MDR Report Key6529737
MDR Text Key74067536
Report Number1219913-2017-00118
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
Reporter Country CodeAR
PMA/PMN Number
K112343
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/27/2017
Device Model NumberN/A
Device Catalogue Number10492493
Device Lot Number39081030
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/11/2017
Initial Date FDA Received04/28/2017
Supplement Dates Manufacturer Received07/31/2017
Supplement Dates FDA Received08/01/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/27/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-